View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pharmatest
3 March 2017

Pharmatest Partners with Biocom and Science Exchange

Pharmatest Services has formed a partnership with California-based organisations Biocom and Science Exchange.

Biocom is one of the largest life science organisations in California, while Science Exchange is one of the leading marketplaces for scientific research. By joining these companies, Pharmatest expects to find new customers and further increase growing US sales.

Pharmatest Services is a contract research organisation, which offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. Pharmatest opened its first US sales office in Boston in early 2013 and its second sales office in San Diego in July 2016. Joining Biocom and Science Exchange is the next step in increasing investments in US marketing for Pharmatest.

San Diego-based Biocom has more than 800 members, many of which are potential customers of Pharmatest. Based in Palo Alto, Science Exchange is one of the largest platforms of research outsourcing in the world. Being a member of Biocom and a Science Exchange verified provider will allow potential customers to find Pharmatest easier and help showcase Pharmatest as a reliable partner with high-quality services.

Chief executive officer (CEO) of Pharmatest Jussi Halleen comments: "Our increased investments in US marketing in recent years have shown their value, as we have increased our US sales by more than 50% per year after 2014.

"I am convinced that joining Biocom and Science Exchange will help us substantially in reaching our goal to achieve at least similar growth figures for our US sales also in the coming years."

4T1 is a triple-negative mouse breast cancer cell line. Pharmatest utilises a 4T1 cell line with stable expression of green fluorescent protein (GFP) enabling easy...
Metastatic and primary tumours are known to respond differently to chemotherapy. Therefore, when establishing drug efficacy it is important not to rely only on experiments...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology